{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:12:24Z","timestamp":1762431144119},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ivar, Ragna og Morten Holes Legat Til Fremme Av Kreftforskningen i Norge"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12032-016-0768-2","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T12:29:27Z","timestamp":1461760167000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Asta","family":"Bye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Wesseltoft-Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Ole","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grete","family":"Skjegstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten B.","family":"Holven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine","family":"Ulven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne J.","family":"Hjermstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"issue":"2","key":"768_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71\u201396. doi: 10.3322\/CA.2007.0010 .","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"768_CR2","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s11605-011-1665-9","volume":"15","author":"PJ Kneuertz","year":"2011","unstructured":"Kneuertz PJ, Cunningham SC, Cameron JL, Torrez S, Tapazoglou N, Herman JM, et al. Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg. 2011;15(11):1917\u201327. doi: 10.1007\/s11605-011-1665-9 .","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"768_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/bjc.1997.17","volume":"75","author":"SJ Wigmore","year":"1997","unstructured":"Wigmore SJ, Plester CE, Richardson RA, Fearon KC. Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer. 1997;75(1):106\u20139.","journal-title":"Br J Cancer"},{"issue":"2","key":"768_CR4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0b013e3283347e77","volume":"26","author":"MJ Tisdale","year":"2010","unstructured":"Tisdale MJ. Cancer cachexia. Curr Opin Gastroenterol. 2010;26(2):146\u201351. doi: 10.1097\/MOG.0b013e3283347e77 .","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"768_CR5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395. doi: 10.1016\/S1470-2045(10)70218-7 .","journal-title":"Lancet Oncol"},{"issue":"4","key":"768_CR6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpainsymman.2006.05.012","volume":"32","author":"JB Hopkinson","year":"2006","unstructured":"Hopkinson JB, Wright DN, McDonald JW, Corner JL. The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manage. 2006;32(4):322\u201331. doi: 10.1016\/j.jpainsymman.2006.05.012 .","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"768_CR7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793\u20139. doi: 10.1016\/j.clnu.2008.06.013 .","journal-title":"Clin Nutr"},{"issue":"6","key":"768_CR8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ctrv.2013.11.007","volume":"40","author":"E Douglas","year":"2014","unstructured":"Douglas E, McMillan DC. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score. Cancer Treat Rev. 2014;40(6):685\u201391.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"768_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.critrevonc.2010.10.004","volume":"80","author":"D Blum","year":"2011","unstructured":"Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P, et al. Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol. 2011;80(1):114\u201344. doi: 10.1016\/j.critrevonc.2010.10.004 .","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"768_CR10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00408-011-9364-6","volume":"190","author":"ST Gulen","year":"2012","unstructured":"Gulen ST, Karadag F, Karul AB, Kilicarslan N, Ceylan E, Kuman NK, et al. Adipokines and systemic inflammation in weight-losing lung cancer patients. Lung. 2012;190(3):327\u201332.","journal-title":"Lung"},{"issue":"6","key":"768_CR11","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/bjc.2014.90","volume":"110","author":"CSD Roxburgh","year":"2014","unstructured":"Roxburgh CSD, McMillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer. 2014;110(6):1409\u201312. doi: 10.1038\/bjc.2014.90 .","journal-title":"Br J Cancer"},{"issue":"3","key":"768_CR12","doi-asserted-by":"crossref","first-page":"M242","DOI":"10.1093\/gerona\/59.3.M242","volume":"59","author":"M Cesari","year":"2004","unstructured":"Cesari M, Penninx BWJH, Pahor M, Lauretani F, Corsi AM, Williams GR, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol Ser A Biol Sci Med Sci. 2004;59(3):M242\u20138. doi: 10.1093\/gerona\/59.3.M242 .","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"3","key":"768_CR13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","volume":"88","author":"A Tuca","year":"2013","unstructured":"Tuca A, Jimenez-Fonseca P, Gascon P. Clinical evaluation and optimal management of cancer cachexia. Crit Rev Oncol Hematol. 2013;88(3):625\u201336. doi: 10.1016\/j.critrevonc.2013.07.015 .","journal-title":"Crit Rev Oncol Hematol"},{"issue":"16","key":"768_CR14","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1158\/1078-0432.CCR-05-0185","volume":"11","author":"ME Martignoni","year":"2005","unstructured":"Martignoni ME, Kunze P, Hildebrandt W, Kunzli B, Berberat P, Giese T, et al. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clin Cancer Res. 2005;11(16):5802\u20138. doi: 10.1158\/1078-0432.CCR-05-0185 .","journal-title":"Clin Cancer Res"},{"issue":"5","key":"768_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat R, Gr\u00fctz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21(5):331\u201344.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"19","key":"768_CR16","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","volume":"19","author":"BJ Laird","year":"2013","unstructured":"Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, et al. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res. 2013;19(19):5456\u201364.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"768_CR17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/SPC.0b013e32835a0c70","volume":"6","author":"P Klepstad","year":"2012","unstructured":"Klepstad P, Kaasa S. The importance and pitfalls of correlational science in palliative care research. Curr Opin Support Palliat Care. 2012;6(4):508\u201313. doi: 10.1097\/SPC.0b013e32835a0c70 .","journal-title":"Curr Opin Support Palliat Care"},{"issue":"8","key":"768_CR18","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15(8):2920\u20136. doi: 10.1158\/1078-0432.CCR-08-2242 .","journal-title":"Clin Cancer Res"},{"issue":"6","key":"768_CR19","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1016\/j.clnme.2012.10.002","volume":"7","author":"N Wesseltoft-Rao","year":"2012","unstructured":"Wesseltoft-Rao N, Holven KB, Telle-Hansen VH, Narverud I, Iversen PO, Hjermstad MJ, et al. Measurements of body fat is associated with markers of inflammation, insulin resistance and lipid levels in both overweight and in lean, healthy subjects. e-SPEN Journal. 2012;7(6):e234\u201340. doi: 10.1016\/j.clnme.2012.10.002 .","journal-title":"e-SPEN Journal"},{"issue":"6","key":"768_CR20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1079\/BJN20051587","volume":"94","author":"IT Lillegaard","year":"2005","unstructured":"Lillegaard IT, Andersen LF. Validation of a pre-coded food diary with energy expenditure, comparison of under-reporters v. acceptable reporters. Br J Nutr. 2005;94(6):998\u20131003.","journal-title":"Br J Nutr"},{"key":"768_CR21","unstructured":"Blaker B, Aarsland M. M\u00e5l og vekt for matvarer. Oslo: Landsforeningen for Kosthold & Helse; 1989. p. 6\u201341."},{"key":"768_CR22","volume-title":"Manual of dietetic practice","author":"B Thomas","year":"1994","unstructured":"Thomas B. Manual of dietetic practice. 2nd ed. Oxford: Blacwell; 1994.","edition":"2"},{"issue":"12","key":"768_CR23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1017\/S0007114512004527","volume":"109","author":"BS Meij van der","year":"2013","unstructured":"van der Meij BS, Schoonbeek CP, Smit EF, Muscaritoli M, van Leeuwen PA, Langius JA. Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks. Br J Nutr. 2013;109(12):2231\u20139. doi: 10.1017\/S0007114512004527 .","journal-title":"Br J Nutr"},{"issue":"10","key":"768_CR24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0895-4356(03)00170-7","volume":"56","author":"JM Engels","year":"2003","unstructured":"Engels JM, Diehr P. Imputation of missing longitudinal data: a comparison of methods. J Clin Epidemiol. 2003;56(10):968\u201376. doi: 10.1016\/S0895-4356(03)00170-7 .","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"768_CR25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.clnu.2012.01.011","volume":"31","author":"M Seelaender","year":"2012","unstructured":"Seelaender M, Batista M Jr, Lira F, Silverio R, Rossi-Fanelli F. Inflammation in cancer cachexia: to resolve or not to resolve (is that the question?). Clin Nutr. 2012;31(4):562\u20136. doi: 10.1016\/j.clnu.2012.01.011 .","journal-title":"Clin Nutr"},{"issue":"3","key":"768_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-015-0497-y","volume":"32","author":"C Bilir","year":"2015","unstructured":"Bilir C, Engin H, Can M, Temi Y, Demirtas D. The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia. Med Oncol. 2015;32(3):1\u20136. doi: 10.1007\/s12032-015-0497-y .","journal-title":"Med Oncol"},{"issue":"5","key":"768_CR27","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1210\/jc.2004-1788","volume":"90","author":"JM Garcia","year":"2005","unstructured":"Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005;90(5):2920\u20136. doi: 10.1210\/jc.2004-1788 .","journal-title":"J Clin Endocrinol Metab"},{"key":"768_CR28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1477-7819-8-85","volume":"8","author":"O Kemik","year":"2010","unstructured":"Kemik O, Sumer A, Kemik AS, Hasirci I, Purisa S, Dulger AC, et al. The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol. 2010;8:85. doi: 10.1186\/1477-7819-8-85 .","journal-title":"World J Surg Oncol"},{"issue":"1","key":"768_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00520-006-0091-0","volume":"15","author":"U Khalid","year":"2006","unstructured":"Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, et al. Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer. 2006;15(1):39\u201346. doi: 10.1007\/s00520-006-0091-0 .","journal-title":"Support Care Cancer"},{"issue":"1","key":"768_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00520-012-1514-8","volume":"21","author":"A Bye","year":"2013","unstructured":"Bye A, Jordhoy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ. Symptoms in advanced pancreatic cancer are of importance for energy intake. Support Care Cancer. 2013;21(1):219\u201327. doi: 10.1007\/s00520-012-1514-8 .","journal-title":"Support Care Cancer"},{"issue":"12","key":"768_CR31","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00520-009-0623-5","volume":"17","author":"T Yavuzsen","year":"2009","unstructured":"Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, LeGrand S, et al. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer. 2009;17(12):1531\u201341. doi: 10.1007\/s00520-009-0623-5 .","journal-title":"Support Care Cancer"},{"issue":"3","key":"768_CR32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/01635581.2015.1004728","volume":"67","author":"N Wesseltoft-Rao","year":"2015","unstructured":"Wesseltoft-Rao N, Hjermstad MJ, Ikdahl T, Dajani O, Ulven SM, Iversen PO, et al. Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer. Nutr Cancer. 2015;67(3):472\u201380.","journal-title":"Nutr Cancer"},{"issue":"1","key":"768_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1586\/eem.11.87","volume":"7","author":"E Kyrana","year":"2012","unstructured":"Kyrana E, Briggs S, Dhawan A. Molecular mechanisms of cachexia in chronic disease. Expert Rev Endocrinol Metab. 2012;7(1):73\u201390. doi: 10.1586\/eem.11.87 .","journal-title":"Expert Rev Endocrinol Metab"},{"key":"768_CR34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/qjmed\/hci127","volume":"98","author":"JN Gordon","year":"2005","unstructured":"Gordon JN, Green SR, Goggin PM. Cancer cachexia. Q J Med. 2005;98:779\u201388. doi: 10.1093\/qjmed\/hci127 .","journal-title":"Q J Med"},{"issue":"4","key":"768_CR35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1499-3872(14)60259-9","volume":"13","author":"R Holmer","year":"2014","unstructured":"Holmer R, Goumas FA, Waetzig GH, Rose-John S, Kalthoff H. Interleukin-6: a villain in the drama of pancreatic cancer development and progression. Hepatobiliary Pancreat Dis Int. 2014;13(4):371\u201380. doi: 10.1016\/S1499-3872(14)60259-9 .","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"12","key":"768_CR36","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/cncr.20672","volume":"101","author":"B Ebrahimi","year":"2004","unstructured":"Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma. Cancer. 2004;101(12):2727\u201336. doi: 10.1002\/cncr.20672 .","journal-title":"Cancer"},{"issue":"1","key":"768_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","volume":"31","author":"C Scheede-Bergdahl","year":"2012","unstructured":"Scheede-Bergdahl C, Watt HL, Trutschnigg B, Kilgour RD, Haggarty A, Lucar E, et al. Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia? Clin Nutr. 2012;31(1):85\u20138. doi: 10.1016\/j.clnu.2011.07.010 .","journal-title":"Clin Nutr"},{"issue":"5","key":"768_CR38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10552-008-9273-z","volume":"20","author":"M Dalamaga","year":"2009","unstructured":"Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, Mitsiades N, et al. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control. 2009;20(5):625\u201333. doi: 10.2307\/40272028 .","journal-title":"Cancer Causes Control"},{"issue":"4","key":"768_CR39","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cncr.21690","volume":"106","author":"I Wolf","year":"2006","unstructured":"Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, et al. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer. 2006;106(4):966\u201373. doi: 10.1002\/cncr.21690 .","journal-title":"Cancer"},{"issue":"4","key":"768_CR40","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1164\/ajrccm.162.4.9912016","volume":"162","author":"EC Creutzberg","year":"2000","unstructured":"Creutzberg EC, Wouters EFM, Vanderhoven-Augustin IML, Dentener MA, Schols AMWJ. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(4):1239\u201345. doi: 10.1164\/ajrccm.162.4.9912016 .","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"768_CR41","first-page":"1","volume":"84","author":"M-D Li","year":"2011","unstructured":"Li M-D. Leptin and beyond: an odyssey to the central control of body weight. Yale J Biol Med. 2011;84(1):1\u20137.","journal-title":"Yale J Biol Med"},{"issue":"02","key":"768_CR42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0007114511005605","volume":"108","author":"B Schautz","year":"2012","unstructured":"Schautz B, Later W, Heller M, Peters A, M\u00fcller MJ, Bosy-Westphal A. Impact of age on leptin and adiponectin independent of adiposity. Br J Nutr. 2012;108(02):363\u201370. doi: 10.1017\/S0007114511005605 .","journal-title":"Br J Nutr"},{"issue":"3","key":"768_CR43","doi-asserted-by":"crossref","first-page":"R674","DOI":"10.1152\/ajpregu.00104.2006","volume":"291","author":"P Costelli","year":"2006","unstructured":"Costelli P, Muscaritoli M, Bossola M, Penna F, Reffo P, Bonetto A, et al. IGF-1 is downregulated in experimental cancer cachexia. Am J Physiol Regul Integr Comp Physiol. 2006;291(3):R674\u2013R83. doi: 10.1152\/ajpregu.00104.2006 .","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"10","key":"768_CR44","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","volume":"103","author":"M Fouladiun","year":"2005","unstructured":"Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care\u2013correlations with food intake, metabolism, exercise capacity, and hormones. Cancer. 2005;103(10):2189\u201398. doi: 10.1002\/cncr.21013 .","journal-title":"Cancer"},{"issue":"8","key":"768_CR45","doi-asserted-by":"crossref","first-page":"702","DOI":"10.18632\/aging.100358","volume":"3","author":"DT Hall","year":"2011","unstructured":"Hall DT, Ma JF, Di Marco S, Gallouzi I-E. Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia. Aging (Albany NY). 2011;3(8):702\u201315.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"768_CR46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000331685","volume":"81","author":"PJ Vlachostergios","year":"2011","unstructured":"Vlachostergios PJ, Gioulbasanis I, Kamposioras K, Georgoulias P, Baracos VE, Ghosh S, et al. Baseline insulin-like growth factor-I plasma levels, systemic inflammation, weight loss and clinical outcome in metastatic non-small cell lung cancer patients. Oncology. 2011;81(2):113\u20138. doi: 10.1159\/000331685 .","journal-title":"Oncology"},{"issue":"1","key":"768_CR47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1191\/0269216302pm486oa","volume":"16","author":"L Thoresen","year":"2002","unstructured":"Thoresen L, Fjeldstad I, Krogstad K, Kaasa S, Falkmer UG. Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med. 2002;16(1):33\u201342.","journal-title":"Palliat Med"},{"issue":"9414","key":"768_CR48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","volume":"363","author":"D Li","year":"2004","unstructured":"Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363(9414):1049\u201357. doi: 10.1016\/S0140-6736(04)15841-8 .","journal-title":"Lancet"},{"issue":"11","key":"768_CR49","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00520-006-0067-0","volume":"14","author":"KJ Labori","year":"2006","unstructured":"Labori KJ, Hjermstad MJ, Wester T, Buanes T, Loge JH. Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study. Support Care Cancer. 2006;14(11):1126\u201333. doi: 10.1007\/s00520-006-0067-0 .","journal-title":"Support Care Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-016-0768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-016-0768-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-016-0768-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:31:56Z","timestamp":1559442716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-016-0768-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s12032-016-0768-2","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]},"article-number":"54"}}